Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition · 2026
DOI: 10.1002/jpn3.70180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2026. Verfasst von Silvana Ancona und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Cholangitis, Sclerosing, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Objectives
Oral vancomycin (OV) has limited usage in paediatric inflammatory bowel disease (PIBD) with reported efficacy in primary sclerosing cholangitis (PSC‐PIBD), acute severe colitis as part of quadruple‐antibiotic regimen, and very early‐onset IBD. This study evaluates OV effectiveness and safety as a single‐agent in non‐PSC PIBD.
Methods
This single‐centre retrospective study included patients on OV for active disease or steroid/topical therapy dependency. Exclusion criteria were PSC diagnosis, Clostridioides difficile infection, induction treatment started
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK.
- Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
- Child Life and Health, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Silvana Ancona, Richard K Russell
Förderung
- None
Zitieren
APA
Ancona, S., Gianolio, L., Armstrong, K., Rabone, R., Merrick, V., Henderson, P., Wilson, D. C., & Russell, R. K. (2026). Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70180
Vancouver
Ancona S, Gianolio L, Armstrong K, Rabone R, Merrick V, Henderson P, et al. Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70180
BibTeX
@article{Ancona2026,
author = {Ancona, Silvana and Gianolio, Laura and Armstrong, Katherine and Rabone, Rosalind and Merrick, Victoria and Henderson, Paul and Wilson, David C and Russell, Richard K},
title = {Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70180}
}
EUVIMED